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Mycobacterium tuberculosis H37Rv escapes host-generated stresses by entering a
dormant persistent state. Activation of toxin-antitoxin modules is one of the mechanisms
known to trigger such a state with low metabolic activity. M. tuberculosis harbors a
large number of TA systems mostly located within discernible genomic islands. We
have investigated the parDE2 operon of M. tuberculosis H37Rv encoding MParE2 toxin
and MParD2 antitoxin proteins. The parDE2 locus was transcriptionally active from
growth phase till late stationary phase in M. tuberculosis. A functional promoter located
upstream of parD2 GTG start-site was identified by 5′-RACE and lacZ reporter assay.
The MParD2 protein transcriptionally regulated the PparDE2 promoter by interacting
through Arg16 and Ser15 residues located in the N-terminus. In Escherichia coli, ectopic
expression of MParE2 inhibited growth in early stages, with a drastic reduction in
colony forming units. Live-dead analysis revealed that the reduction was not due to
cell death alone but due to formation of viable but non-culturable cells (VBNCs) also.
The toxic activity of the protein, identified in the C-terminal residues Glu98 and Arg102,
was neutralized by the antitoxin MParD2, both in vivo and in vitro. MParE2 inhibited
mycobacterial DNA gyrase and interacted with the GyrB subunit without affecting its
ATPase activity. Introduction of parE2 gene in the heterologous M. smegmatis host
prevented growth and colony formation by the transformed cells. An M. smegmatis
strain containing the parDE2 operon also switched to a non-culturable phenotype in
response to oxidative stress. Loss in colony-forming ability of a major part of the MParE2
expressing cells suggests its potential role in dormancy, a cellular strategy for adaptation
to environmental stresses. Our study has laid the foundation for future investigations to
explore the physiological significance of parDE2 operon in mycobacterial pathogenesis.
Keywords: Mycobacterium tuberculosis, ParDE2, DNA gyrase inhibitor, bacteriostasis, VBNC, stress response,
toxin–antitoxin system, selfish genes
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INTRODUCTION
Tuberculosis (TB) continues to be a global health problem due
to increasing morbidity and mortality. According to World
Health Organization, 9.6 million people developed TB in 2014
and 1.5 million died from the disease1. The leading causes of
high incidence of Mycobacterium tuberculosis (Mtb) infection
are the emergence of drug resistant strains, persistence, latency-
mediated reactivation of the pathogen and HIV-associated
immunodeficiency. M. tuberculosis acquires its pathogenicity
by virtue of its unique virulence factors that have made it
better adapted to persist chronically in hostile niches within the
host.
Mycobacteria often embrace a non-replicative persistent,
quiescent state, enabling them to evade unfavorable conditions
like hypoxia, oxidative stress and acidic pH etc., typically
encountered within the host macrophages (Wu et al., 2012).
A similar non-replicating state is triggered under stress by
the activation of toxin–antitoxin (TA) systems, suggesting
that specific TA systems may be involved in adaptation to
environmental cues in the host (Lewis, 2007). The TA systems
on the one hand protect the bacterial cells from stressful
conditions (Ramage et al., 2009), while on the other they
initiate programmed cell death for the benefit of the population
(Ramage et al., 2009). Genome sequence analysis revealed that
the Mtb H37Rv harbors 88 putative TA systems which are mostly
located within discernible genomic islands and likely acquired
by recent events of horizontal gene transfer. A majority of these
are conserved in M. tuberculosis complex (MTBC) but absent
in other non-pathogenic mycobacteria suggesting a potential
contribution to the pathogenic lifestyle of Mtb (Ramage et al.,
2009).
The first TA system was originally identified as an extra-
chromosomal genetic element involved in post-segregational
killing (PSK) of plasmid-free daughter cells to ensure stable
maintenance of the plasmid in a population of bacteria (Ogura
and Hiraga, 1983). TA systems are widely distributed in both
bacteria and archaea (Yamaguchi et al., 2011). Currently known
TA systems are classified into three canonical types, majority
of them belong to type II family, that is typically a two-gene
operon model, encoding an antitoxin protein which binds to and
precludes the cognate toxin protein from disrupting an essential
cellular function (Gerdes et al., 2005). The ‘addiction’ mechanism
behind plasmid inheritance relies upon differential stability of
the labile antitoxin protein that is prone to protease degradation,
compared to the stable toxin. The antitoxin is degraded in the
daughter cells lacking the plasmid, thereby releasing the toxin
from the TA complex, which leads to toxin-mediated growth
inhibition and/or killing (Melderen et al., 1994; Lehnherr and
Yarmolinsky, 1995). From an evolutionary point of view, TA
systems are ‘selfish’ genetic elements that ensure their own vertical
transmission by post-segregational host killing for reasons of
adaptive advantage (Van Melderen and De Bast, 2009). This
is analogous to maintenance of type II restriction-modification
(R-M) systems, where post-segregational host killing ensures
1http://www.who.int/mediacentre/factsheets/fs104/en/
inheritance of the R-M system as a unit (Naito et al., 1995;
Kobayashi, 2001).
The post-genomic era has revealed that TA modules are
diverse and ubiquitous in prokaryotic genomes as a consequence
of horizontal gene transfer. TA loci along with a vast collection
of transposons, phages and integrative and conjugative elements
constitute the ‘mobilome’ of bacteria. The chromosomal toxins
which are either DNA replication or protein synthesis inhibitor
belong to nine phylogenetically distinct classes (Hayes and Van
Melderen, 2011). The most well-investigated, genome-encoded
TA systems have come from the pioneering work in Escherichia
coli (Gerdes et al., 2005). A few of these modules are triggered
under stress leading either to cell stasis or programmed cell
death (Ramage et al., 2009). Thus, the role of TA systems,
especially those borne on the nucleoid, as agents of adaptation
and evolution in prokaryotes is likely to be significant.
The prototypic CcdB and ParE proteins of E. coli are the
toxin components of the CcdAB and ParDE TA systems, encoded
by broad host range F and Rk2 plasmids, respectively (Bernard
and Couturier, 1992; Jiang et al., 2002). Notwithstanding low
similarity at amino acid level, both CcdB and ParE block DNA
replication and transcription by inhibiting DNA gyrase in a
manner similar to that of fluoroquinolone antibiotics (Jiang
et al., 2002), although they recognize different regions of DNA
gyrase (Yuan et al., 2010). ParE toxins share considerable protein
sequence homology with the toxin components of the RelBE
family that poison the translation machinery of a cell (Pandey
and Gerdes, 2005). The RK2-encoded negatively charged ParD
antitoxin dimer was shown to neutralize the positively charged
ParE toxin by forming a stable D2E2 tetramer complex (Roberts
et al., 1993; Johnson et al., 1996; Dalton and Crosson, 2010).
The N-terminal half of ParD adopts a ribbon-helix-helix (RHH)
fold and auto-regulates the parDE operon negatively (Oberer
et al., 2007). Genome-encoded parDE TA systems are widespread
within the γ-proteobacterium class (Anantharaman and Aravind,
2003). Caulobacter crescentus, an α-proteobacterium, encodes
three functional parDE modules that are differentially and
independently regulated under various stress conditions (Fiebig
et al., 2010). Three homologs of RK2 encoded parDE loci,
reported in the Gram-negative rod Vibrio cholerae superintegron,
were found to be active in E. coli also (Yuan et al., 2011).
The topological stress generated during DNA replication and
transcription is relieved by DNA gyrase (a type II topoisomerase)
via a strand breakage and re-joining process in an energy-
dependant manner, thereby maintaining the correct level of
chromosomal super-helicity for apt functioning of essential
cellular processes (Reece et al., 1991; Schoeﬄer and Berger,
2008). The ParE2 of V. cholera, like the CcdB toxin and
quinolone antibiotics, targets the GyrA subunit of the DNA
gyrase holoenzyme (an A2B2 tetramer) and stalls the DNA-gyrase
cleavage complex (Loris et al., 1999; Yuan et al., 2010).
Based on the DNA sequence homology, two parDE family
members, Rv1960c-Rv1959c (parDE1) and Rv2142A-Rv2142c
(parDE2) were identified in M. tuberculosis H37Rv genome
(Ramage et al., 2009). This study provides a comprehensive
overview of the parDE2 locus of M. tuberculosis H37Rv. We
report genetic organization and transcriptional regulation of
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the operon, and describe biochemical characteristics of the
MParD2 and MParE2 proteins. We also investigate its potential
involvement in adaptation to environmental stresses using
heterologous hosts- E. coli and M. smegmatis.
EXPERIMENTAL PROCEDURES
Bacterial Strain, Plasmid, and Culture
Conditions
The plasmids and bacterial strains used in this study are listed
in Table 1. E. coli strains used for cloning were grown under
standard conditions in Luria-Bertani (LB) medium (Difco).
M. tuberculosis and M. smegmatis strains were grown in
Middlebrook 7H10 agar (Difco) containing 10% (v/v) oleic
acid, albumin, dextrose and catalase (OADC; Becton Dickinson)
enrichment and 0.5% (v/v) glycerol, or in 7H9 broth (Difco)
supplemented with 10% (v/v) albumin, dextrose and catalase
(ADC; Becton Dickinson), 0.2% (v/v) glycerol and 0.05% (v/v)
Tween 80 (Chandra et al., 2010). Unless indicated otherwise, all
cultures were grown at 37◦C, with shaking at 180 rpm.
Protein Expression and Purification
The DNA encoding gyrA, gyrB, parD2, parE2, and parDE2 loci
of M. tuberculosis H37Rv were amplified by PCR and cloned in
suitable expression vectors (Table 1), with His6 tag in N-termini.
Briefly, one liter culture of recombinant E. coli strains EC1,
EC2, and EC3 were grown at 37◦C in LB supplemented with
appropriate antibiotics to an A600 of ∼0.6. Protein expression
was induced with 1mM isopropyl-β-D-thiogalactopyranoside
(IPTG) or 0.2% L-arabinose, and incubation was continued
for an additional 4 h at 37◦C for MParE2 and MParD2; and
8 h at 30◦C for GyrA and GyrB, respectively. The cells were
lysed by sonication and the His6-tagged proteins were purified
using Ni-NTA affinity chromatography (Qiagen). The column
was equilibrated with binding buffer B (50 mM Tris-Cl, pH
8.0, 300 mM NaCl, 20 mM imidazole, 5% glycerol) and the
cell lysate was loaded. After washing with buffer W (buffer B
containing 50 mM imidazole), recombinant proteins were eluted
from the column with a 20-ml linear imidazole gradient (20–
500 mM imidazole). Fractions containing pure protein (purity
>90% estimated by SDS-PAGE) were pooled and dialyzed at 4◦C
overnight, in protein storage buffer (buffer B containing 2 mM
βME, 20% glycerol).
The MParD2 protein was further purified by heparin-
sepharose CL-6B affinity chromatography (GE Healthcare). The
column was equilibrated in 25 mM phosphate buffer (pH 7.4)
containing 0.1 M NaCl and the same buffer was used for MParD2
binding and washing. Protein was eluted using a linear 0.1 M
to 1.5 M NaCl gradient and 0.5 ml fractions were collected.
The fractions eluting at 0.4 to 0.7 M NaCl were pooled and
dialyzed in potassium glutamate buffer R (40 mM Tris–HCl
pH 7.4, 100 mM potassium glutamate, 10 mM MgCl2, 25 mM
KCl, 4 mM DTT and 10% glycerol) and checked for DNase
contamination by incubation with supercoiled plasmid DNA.
The MParE2 protein was purified from the inclusion bodies by
Ni-NTA affinity chromatography under denaturing conditions as
described before (Singh et al., 2004). The fractions were analyzed
by 12% SDS–PAGE. The fractions containing the recombinant
MParE2 were pooled, concentrated, and dialyzed against protein
storage buffer (see above) and stored at 4◦C. For preparing
MParE2 without the His6-tag, an N-terminal thrombin cleavage
site was inserted before the start codon in the parE2 gene and
sub-cloned in the pBAD/HisA expression vector using NcoI and
HindIII sites.
For surface plasmon resonance (SPR) experiments the
proteins were purified further. The recombinant GyrA and GyrB
proteins obtained from Ni-NTA affinity chromatography were
further purified to >99% purity by Superdex-200 pg column.
Fractions were pooled and dialyzed in 1XHBS-N buffer (10 mm
HEPES pH 7.4, 150 mm NaCl). The MParE2 purified by Ni-
NTA under denaturing conditions was concentrated and dialyzed
in 1X cleavage buffer (50 mM Tris-HCl pH 8.0, 10 mM CaCl2
and 100 mM NaCl). The N-terminal His6-tag was removed
by using RECOMT Thrombin Cleavage Kit (Sigma) according
to the manufactures protocol. The flow-through fraction was
subjected to Ni-NTA chromatography again to remove any
residual His6-MParE2. Unbound fraction was collected and
dialyzed in 1XHBS-N buffer for further use.
Deletion and Point Mutations in MParE2
and MParD2
The MParE2 variant with C-terminal deletion of 10 amino
acid residues, MParE2110 (1–95 residues) was generated by
polymerase chain reaction using the wild type parE2 gene as
the template and deletion primers (Supplementary Figure S3). In
MParE2, Pro92, Glu96, Glu98, Ile99, Ser100, and Arg102 residues
were substituted individually with alanine, using appropriate
primers (Supplementary Figure S3). In MParD2 the amino acid
residues Leu8, Val11, Ser15, Arg16, and Glu21 in the N-terminus
were substituted individually by alanine using suitable primers
(Supplementary Figure S3). All the protein variants were cloned
in the pBAD/HisA vector and transformed in E. coli TOP10 cells.
Growth profile and cellular viability of the strains (EC6 to EC17)
was monitored after L-arabinose induction as described above.
The MParD2 variants were purified similar to wild-type MParD2
protein.
RNA Extraction and Semi-Quantitative
Reverse Transcriptase PCR
Cultures of M. tuberculosis were grown in 7H9 medium,
cells were harvested at different time points (10, 20, and
30 days), and cells were lysed using TRIzol (Invitrogen)
with ceramic beads in a MagNA-Lyser (Roche). RNA was
extracted with chloroform/isoamyl alcohol. Contaminating DNA
was removed by digestion with DNase-I according to the
manufacturer’s instructions (Promega), and confirmed by PCR
using parDE2 operon-specific primers. For RT-PCR, the Qiagen
one-step Reverse Transcriptase kit was used according to
the manufacturer’s instructions (Qiagen). RNA was reverse
transcribed and the cDNA was amplified with parDE2 operon-
specific primers over 28 cycles of PCR. The secreted antigen
ESAT-6 gene (esxA) was used as positive control.
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TABLE 1 | Bacterial strains and plasmids used in this study.
Relevant characteristic(s) Source
Plasmids
pGEM-T Easy Ampr; PCR TA-cloning vector Promega
pMV261 kanr; E. coli–mycobacterial shuttle vector Stover et al., 1991
pYUB1062 Hygr; E. coli–mycobacterial shuttle vector Wang et al., 2010
pET28(a) kanr, T7 promoter; E. coli expression vector Novagen
pBAD/HisA Ampr, araBAD promoter; E. coli expression vector Invitrogen
pGEX4Tl Ampr, tac promoter; E. coli expression vector GE Healthcare
pMSl pMV261 containing promoter-less lacZ This study
pMS2 pMV261 containing P363parD2-lacZ This study
pMS3 pMS2 containing PgroEL-parD2 This study
pMS4 pMS2 containing PgroEL-parDE2 This study
pMS5 pYUB1062 containing 318-bp parE2 This study
pMS6 pYUB1062 containing 258-bp parE2110 amino acids This study
pMS7 pYUB1062 containing 530-bp parDE2 together This study
pMS8 pMV261 containing parDE2 operon This study
pMS9 pMV261 containing parDE2A10 operon This study
pMSlO pMV261 containing parD2 This study
pMSll pMV261 containing parDE2 This study
pECl pET28(a) containing 2,517-bp M. tuberculosis gyrA This study
pEC2 pET28(a) containing 2,145-bp M. tuberculosis gyrB This study
pEC3 pBAD/HisA containing 216-bp parD2 This study
pEC4 pBAD/HisA containing 318-bp parE2 This study
pEC5 pBAD/HisA containing 530-bp parDE2 This study
pEC6 pBAD/HisA containing parE2110 amino acids This study
pEC7 pBAD/HisA containing parE2P92A mutant This study
pEC8 pBAD/HisA containing parE2E96A mutant This study
pEC9 pBAD/HisA containing parE2 E98A mutant This study
pECIO pBAD/HisA containing parE2I99A mutant This study
pECll pBAD/HisA containing parE2S100A mutant This study
pEC12 pBAD/HisA containing parE2R102A mutant This study
pEC13 pBAD/HisA containing parD2L8A mutant This study
pEC14 pBAD/HisA containing parD2V11A mutant This study
pEC15 pBAD/HisA containing parD2S15A mutant This study
pEC16 pBAD/HisA containing parD2R16A mutant This study
pEC17 pBAD/HisA containing parD2E21A mutant This study
pEC18 pGEX4T1 containing 216-bp parD2 This study
Bacterial Strains
M. tuberculosis H37Rv Wild type ATCC
M. smegmatis mc2 155 ept-1, efficient plasmid transformation mutant of mc26 ATCC
M. smegmatis mc2 4517 M. smegmatis mc2 155 with T7 RNA polymerase Wang et al., 2010
E. coli TOP 10 recAlaraD1391(ara-leu)7697 galU galK rpsL(Strr) Invitrogen
E. coli BL21 (DE3) F− ompT gal dcm Ion hsdSB(rB− mB−)λ (DE3) Novagen
E. coli RosettaTM (DE3) pLysS F− ompT hsdSB(RB− mB−) gal dcmλ(DE3 [lacI lacUV5-T7
gene 1 ind1 sam 7 nin 5]) pLysSRARE (Camr)
Novagen
MS1 M. smegmatis mc2 155 transformed with pMS1 This study
MS2 M. smegmatis mc2 155 transformed with pMS2 This study
MS3 M. smegmatis mc2 155 transformed with pMS3 This study
MS4 M. smegmatis mc2 155 transformed with pMS4 This study
MS5 M. smegmatis mc2 4517 transformed with pMS5 This study
MS6 M. smegmatis mc2 4517 transformed with pMS6 This study
MS7 M. smegmatis mc2 4517 transformed with pMS7 This study
MS8 M. smegmatis mc2 155 transformed with pMS8 This study
MS9 M. smegmatis mc2 155 transformed with pMS9 This study
(Continued)
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TABLE 1 | Continued
Relevant characteristic(s) Source
MS10 M. smegmatis mc2 155 transformed with pMS10 This study
MS11 M. smegmatis mc2 155 transformed with pMS11 This study
MS 12 M. smegmatis mc2 155 transformed with pMV261 This study
EC1 E. coli BL21(DE3) transformed with pEC1 This study
EC2 E. coli BL21(DE3) transformed with pEC2 This study
EC3 E. coli TOP10 transformed with pEC3 This study
EC4 E. coli TOP10 transformed with pEC4 This study
EC5 E. coli TOP10 transformed with pEC5 This study
EC6 E. coli TOP10 transformed with pEC6 This study
EC7 E. coli TOP10 transformed with pEC7 This study
EC8 E. coli TOP10 transformed with pEC8 This study
EC9 E. coli TOP10 transformed with pEC9 This study
EC10 E. coli TOP10 transformed with pEC10 This study
EC11 E. coli TOP10 transformed with pEC11 This study
EC12 E. coli TOP10 transformed with pEC12 This study
EC13 E. coli TOP10 transformed with pEC13 This study
EC14 E. coli TOP10 transformed with pEC14 This study
EC15 E. coli TOP10 transformed with pEC15 This study
EC16 E. coli TOP10 transformed with pEC16 This study
EC17 E. coli TOP10 transformed with pEC17 This study
EC18 E. coli BL21(DE3) transformed with pEC18 This study
Real-Time PCR
The transcription profile of three commonly used reference genes
(Rocha et al., 2015), rrsG, idnT, and rpoD encoding the 16S
rRNA, the L-idonate/5-ketogluconate/gluconate transporter and
the sigma 70 (sigma D) subunit, respectively, were quantified by
qPCR in EC4 and vector control E. coli strains after induction
with L-arabinose for 4 h. Primers were designed using GenScript
Real-time PCR (TaqMan) Primer Design tool and synthesized
by Sigma–Aldrich. Genomic DNA free, total RNA was obtained
as described above. Real-time PCR was performed with a
Stratagene Mx3000P (Agilent Technologies) using the High-
Capacity cDNA Reverse Transcription Kit and SYBR Select
Master Mix (Applied Biosystems) under conditions as mentioned
earlier (Lee et al., 2010). Data was analyzed using Stratagene
MxPro QPCR software version 4.10.
Fusion of Mtb parD2 Upstream
Sequence with lacZ Reporter Gene and
Evaluation of Promoter Activity
The 363-bp upstream region preceding the parD2 start codon
(P363parD2) of M. tuberculosis H37Rv was PCR-amplified and
fused to a promoter-less lacZ reporter gene (3,067 bp) in pSK6
plasmid (Kant et al., 2009). The 363-bp lacZ fusion fragment
was subsequently cloned in an E. coli-Mycobacterium shuttle
vector pMV261, using NotI and DraI sites, forming pMS2
(Supplementary Figure S2). A promoter-less lacZ gene cloned
in pMV261 (pMS1) was used as negative control. For parDE2
transcriptional regulation studies, parD2 or parDE2 coding
sequences were placed downstream of the groEL promoter of
pMS2, at restriction sites EcoR1 and HindIII, to form pMS3
and pMS4, respectively (Supplementary Figure S2). All these
recombinant constructs were electroporated into M. smegmatis
mc2 155.
β-galactosidase activity in all the M. smegmatis recombinants
was determined colorimetrically using O-nitrophenyl-β-D-
galactopyranoside (ONPG; Sigma), as described earlier (Miller,
1972; Dellagostin et al., 1995). Absorbance was measured at
420 nm on a Cecil Aquarius CE 7500 Spectrophotometer. One
unit of β-galactosidase is the amount of enzyme producing
1 nmol of O-nitrophenol per min at 30◦C. Each experiment was
performed thrice in triplicate.
Mapping the 5′ End of the parDE2
Transcript
Total RNA was extracted from M. tuberculosis H37Rv as before
and after DNaseI (Promega) treatment, 5′ Rapid amplification of
cDNA ends (RACE) was performed according to manufacturer’s
protocol (Invitrogen). The RT reaction was performed with
D2-GSPI (5′-TCATCCGAGCCGGGCGCGGATCCG-3′) and
then PCR Amplified with the Abridged Anchor Primer
(AAP, Invitrogen) and D2-GSPII (5′-GGATCCGCTTGTCGA
AGTCATCAA-3′). The final PCR product was cloned in pGEM-
T Easy TA cloning vector and sequenced using T7 and SP6
promoter-specific universal primers.
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Electrophoretic Mobility Shift Assay
(EMSA)
His6-tagged MParD2 protein was purified as described above
and dialysed against 1X EMSA binding buffer (10 mM Tris-HCl
pH 8.0, 1 mM DTT, 2.5 mM MgCl2, 40 mM KCl, 0.5 µg ul−1
dI:dC, 5% glycerol). The 200 bp upstream of the parD2 start site,
P200parD2 was PCR amplified, end-labeled with [γ-32P]-ATP using
T4 polynucleotide kinase (Promega) and purified using G-25
MicroSpin column (GE Healthcare). The MParD2 or the variant
proteins were incubated with 20,000 cpm radiolabelled P200parD2
in 1X EMSA binding buffer at room temperature for 20 min, in
a reaction mix of 25 µl. Non-denaturing DNA loading dye was
added to the reaction mixture and electrophoresed on 5% Native-
PAGE gel in 0.5X TBE buffer at 4◦C at 60 V till bromophenol
blue reached the bottom. The gel was dried and exposed to a
phosphorimager screen (Amersham Biosciences) overnight and
scanned in a Typhoon Imager (GE Healthcare).
ANS Binding Assay
8-Anilinonaphthalene-1-sulfonic acid (ANS) was dissolved in
100 mM phosphate buffer to a final concentration of 500 µM.
ANS fluorescence measurements as a function of protein folding
were performed at 25◦C at an excitation wavelength of 350 nm
and the emission spectra was recorded from 360 to 600 nm
(Taylor and Kneale, 2009). One µM MParD2 or variant proteins
were mixed with 5 µM of ANS, to get stable fluorescence
emission. Subsequently, 0.12 µM P200parD2 DNA was added
to the MParD2-ANS mix and changes in the fluorescent
intensities at emission maxima (480 nm) were determined.
Control experiments lacking either the MParD2 antitoxin or
the P200parD2 DNA were also included. The fluorescent intensity
emitted by 5 µM ANS in 100 mM phosphate buffer was set as the
baseline and hence subtracted from all the sample readings.
Growth of E. coli and M. smegmatis
Strains Containing parE2 and parDE2
Escherichia coli strains were grown in LB medium containing
100 µg ml−1 of ampicillin and 50 µg ml−1 of streptomycin at
37◦C. Freshly inoculated cultures were grown for 2 h (MParE2
expressing cultures were grown for 6 h as they grow slowly),
till OD600 ∼0.5, and induced with 0.2% L-Arabinose (final
concentration). Samples were aseptically withdrawn at regular
intervals and growth was monitored by measuring OD600 and
colony forming units (CFU) by serial dilution and plating on LB
agar plates containing suitable antibiotics. In another experiment
the incubation was terminated after 4 h, cells were washed
with LB medium and re-suspended in same volume of fresh
LB medium containing appropriate antibiotics and 0.2% D-
glucose to stop toxin expression and incubation was continued.
The recombinant E. coli strains were also induced in different
growth phases corresponding to OD600 of 0.33, 0.78, 1.12, and
1.61. MParE2 expression and toxicity was examined by western
blotting and CFU counts.
Mycobacterium smegmatis recombinant strains were
generated by electroporating wt-parE2 and parDE2 DNA
cloned in the E. coli-mycobacterial shuttle vector pYUB1062,
into electro-competent M. smegmatis mc2 4517 cells (using 10%
glycerol) and selecting transformants on 7H10 agar containing
OADC supplement and 50 µg ml−1 hygromycin.
Measurement of Viability by SYBR Green
I/Propidium Iodide Assay
To assay cell viability of MParE2 expressing E. coli cells, the
EC4 and EC5 strains were grown to log phase (A600 ∼0.5) and
protein expression was induced with 0.2% L-arabinose for 4 h
at 37◦C. Cells were harvested after 2, 4, 8, 12, and 20 h post
induction; washed and diluted in 1X PBS (pH 7.4). The assays
were performed in 96 well microplates (Feng et al., 2014b). For
staining, 10 µl of SYBR Green I (10,000X stock; Lumiprobe) was
mixed with 30 µl of propidium iodide (PI; 20 mM; Sigma) and
the mixture was added to 960 µl of sterile 1X PBS and vortexed.
Ten microliters of freshly prepared staining mixture were added
to each well containing ∼1 × 106 cells. The excitation/emission
maxima are 485/535 nm for SYBR Green I (Green emission) and
485/635 nm for PI (Red emission). The Green (G) and Red (R)
fluorescence intensities were measured using SpectraMax R© M3
Multi-Mode Microplate Reader, Molecular Devices; followed by
data acquisition and analysis using SoftMax Pro 6.3 software.
For quantitative estimation, a standard curve was prepared by
mixing 100% live and 100% dead (Isopropanol treated) E. coli
cells in different proportions (viz. 10:0, 8:2, 5:5, 2:8, 0:10) and
the resulting G/R fluorescence ratio was plotted. The association
between percentage cell viability and corresponding green/red
fluorescence was obtained from a regression equation and curve
following the least-square fitting method. Sparfloxacin (0.1 µg
ml−1) treated E. coli cells containing pBAD/HisA were used as
a positive control.
Scanning Electron Microscopy (SEM)
Surface topography of the bacterial cells was evaluated by SEM
analysis as described earlier (Singh and Mukhopadhyay, 2011).
EC4 and EC5 cells were induced and harvested by centrifugation,
washed three times with 1X PBS (pH 7.2) and fixed with 2.5%
(v/v) glutaraldehyde in 0.1 M phosphate buffer (pH 7.2), at 4◦C,
overnight. The fixed cells were washed three times with 0.1 M
phosphate buffer (pH 7.2) and dehydrated in a series of graded
ethanol solutions and dried with hexamethyldisilazane (HMDS)
on cover slips and mounted on the SEM stub. Samples were
viewed on a Carl Zeiss EVO 40 scanning electron microscope at
20 KeV.
Interaction of MParE2 Toxin with MParD2
Antitoxin
GST-tagged MParD2 and GST tag alone (as negative-bait
control) were purified as follows: IPTG-induced 500 ml EC18
culture was harvested and lysed by sonication in 20 ml binding
Buffer-A (50 mM Tris-Cl pH 7.5, 50 mM NaCl, 5% glycerol
and 1 mM EDTA). The lysate was loaded on a glutathione
sepharose affinity column (GE Life Sciences) and eluted in
Buffer-A containing reduced glutathione. The purified GST-D2
or GST proteins (after dialysis against buffer A) were mixed
with partially purified His6X-MParE2 in Buffer A and incubated
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overnight at 4◦C for interaction. The mixture was loaded on a
glutathione sepharose column, washed with Buffer-A containing
2 mM reduced glutathione and eluted in Buffer-B (Buffer-A
containing 300 mM NaCl and 20 mM reduced glutathione). The
eluted fractions were concentrated by Amicon-ULTRA (MWCO
3KDa) filtration. Partially purified His6X-Domain 4 (PA-D4)
of the protective antigen of Bacillus anthracis (Manish et al.,
2013) was used as non-specific protein-prey control. Protein
samples were resolved using SDS-PAGE and immunoblotting
was performed using anti-GST (Santa Cruz biotech) and anti-His
(Sigma) monoclonal antibodies.
Purification and Reconstitution of
Mycobacterial DNA Gyrase A2B2
Holoenzyme
Purified Mtb GyrA and GyrB subunits were mixed in a molar
ratio of 1:1.5 and dialysed against potassium glutamate Buffer
R. The reconstituted mixture was applied to a Superdex-200
pg column (16/600 HR; Amersham Pharmacia Biotech) pre-
equilibrated with Buffer R and resolved using an AKTA FPLC
system (Amersham Pharmacia Biotech). The molecular weights
of the proteins were estimated by Blue Native-PAGE and SDS-
PAGE with appropriate standards (data not shown).
DNA Supercoiling Assays
The DNA gyrase supercoiling activity was determined by
measuring the conversion of relaxed plasmid pBR322 DNA to
the supercoiled form. The relaxed pBR322 DNA was prepared
from the supercoiled form (Inspiralis Ltd.) by treatment with
wheat germ topoisomerase-I as described by the manufacturer
(Promega). The supercoiling reactions were carried out as
follows: A standard reaction mixture of 30 µl contained
30 mM Tris-Cl (pH 7.4), 25 mM KCl, 10 mM MgCl2,
2 mM spermidine, 3 mM DTT, 0.1 mg ml−1 yeast tRNA,
0.42 mg ml−1 BSA, 120 mM potassium glutamate, 1 mM
ATP, nuclease-free water, 1 µg of relaxed pBR322 plasmid
DNA as substrate and variable amounts of Mtb DNA gyrase
holoenzyme. The reaction mixture was incubated at 37◦C for
1 h, and terminated by the addition of 0.1% SDS and 100 µg
ml−1proteinase K; followed by further incubation for 30 min
at 37◦C. The reaction mixture was subjected to electrophoresis
in a 0.8% agarose gel in 0.5X TBE buffer (Tris-borate-EDTA,
pH 8.3) overnight at 25 V, and the gel was stained with
ethidium bromide (1 µg ml−1). One unit of enzyme activity
was defined as the amount of DNA gyrase that converted
1 µg of relaxed pBR322 to the supercoiled form in 1 h at
37◦C.
For inhibition and reversal of DNA gyrase activity,
supercoiling assay was carried out as above in the presence
of toxin or toxin and antitoxin together. For each reaction 1
unit of DNA gyrase holoenzyme was used. For inhibition, 1.3,
2.6, and 5.3 µM MParE2 was mixed with 1 unit of DNA gyrase
individually and incubated for 30 min at RT before commencing
the supercoiling assay. To reverse the inhibitory effect of the
toxin, 5.3 µM MParE2 was mixed with 3.6, 7.2, and 10.9 µM
MParD2, prior to addition of DNA Gyrase. Sparfloxacin (a
fluoroquinolone) at concentrations of 2 and 5 µg ml−1 was used
as positive control for gyrase inhibition in the DNA gyrase assay.
The ATPase activity of the GyrB protein was tested as described
earlier (Anderle et al., 2008).
Interaction of MParE2 with DNA Gyrase
Subunits
To examine the interaction of MParE2 with DNA gyrase subunits,
isothermal titration calorimetry (ITC) was performed at 25◦C
using the MicroCal iTC200 system (GE Healthcare). For all
isotherms, the sample cell was filled with 300 µl of 70 µM
GyrA/GyrB and the syringe was loaded with 700 µM ParE2 toxin.
Each binding isotherm was obtained from 20 injections of ParE2
toxin (2 µl each) at 25◦C, with a spacing of 150 s to allow for
the re-attainment of a differential power baseline of 9.0 µcal
s−1. The stirring speed and reference power were 1000 rpm and
5 µcal s−1, respectively. Binding isotherms were integrated and
analyzed using Origin v7.0 software (MicroCal).
SPR experiments were performed using BIAcore R© T200
(GE Healthcare). GyrA and GyrB subunits were captured via
their N-terminal His6-tags by monoclonal anti-His antibody
immobilized on a CM4 sensor chip (carboxymethylated dextran
chips, GE Healthcare) at a surface density of 2,500 RU, using
amine-coupling chemistry. The kinetic studies were setup by
passing different analyte concentrations ranging from 1.1 to
18 µM at 20 µl min−1 with a dissociation time of 600 s.
Association time was kept constant at 180 s. Regeneration was
subsequently performed by injecting 40 µl of regeneration buffer
(10 mM glycine pH 2.1) at 10 µl min−1. Binding of MParE2
to the GyrA and GyrB subunits was analyzed by the BIAcore R©
evaluation software. Sparfloxacin binding to immobilized GyrA
subunit was used as a positive control.
Exposure of M. smegmatis Containing
the parDE2 Operon to Stress Conditions
To examine the role of parDE2 operon in M. smegmatis,
recombinant strains were subjected to various stress conditions
and viability of the cultures was determined. MS8 (containing
wt-parDE2 operon), MS9 (containing C′-terminal truncated
parDE2 operon) and MS12 (pMV261 vector control) strains
were inoculated into 7H9 broth with supplements and 40 µg
ml−1 kanamycin, and grown at 37◦C with shaking at 180 rpm.
Aliquots were withdrawn at different time points, washed with
fresh 7H9 broth and subjected to different stress conditions.
CFU counts were determined before and after stress treatment
by plating serial dilutions on 7H10 agar plates containing 40 µg
ml−1kanamycin and incubated at 37◦C for 3–4 days.
For exposure to hypoxia, mycobacterial cultures were grown
as above. At OD600 ∼1.0, 22.5 ml of each culture was aseptically
transferred to sterile 25-ml roller bottles (20 mm × 150 mm),
with an aeration space of less than 10%. The caps were sealed
with parafilm and the cultures were incubated at 37◦C with
gentle rotation (20 rpm). Samples were taken at 5 and 10 days
and CFUs were counted. Oxidative stress was applied with
addition of diethylenetriamine/nitric oxide-adduct (DETA/NO)
to the cultures in different growth phases – OD600∼0.6 (mid
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log), 1.4 (early stationary) and 2.1 (late stationary) – to a final
concentration of 10 mM, and incubation continued. Samples
were taken at different time points and CFU were determined.
Vitamin C-mediated oxidative stress was generated as described
by Vilchèze et al. (2013) with modifications. Briefly, all the three
strains were grown in 7H9 medium supplemented with 10%
(v/v) ADC supplement without catalase. Cells from different
growth phases were drawn and exposed to Vitamin C at a
final concentration of 6 mM. Samples were removed after 2
and 8 h and plated for CFU counts. For temperature stress,
the strains were incubated at 37◦C and 42◦C, with shaking at
150 rpm. Samples were withdrawn at 24 h intervals and CFUs
were recorded. For nutrient starvation, 50 ml cultures of the
three strains were grown to an OD600 of ∼0.6, harvested and
washed with sterile 1X PBS (pH 6.6). The cell pellets were
suspended in 50 ml sterile 1X PBS (pH-6.6) and incubated
at 37◦C. Viability of the cultures was monitored after 5 and
10 days by CFU counting. To study the effect of iron depletion,
cells were harvested and transferred to RH defined medium
(Ratledge and Hall, 1971) without FeSO4.7H2O, containing
100 µM deferoxamine mesylate salt (Sigma). Samples were
plated at different time points for CFU counts. Acid stress
was applied by suspending the cells grown to an OD600
∼0.6 in 7H9 medium with pH adjusted to 4.0. The pH
was monitored at the start and end of the experiment with
pH indicator strips. Samples were plated on 7H10 agar for
CFU counts. Each experiment was performed in triplicate, at
least thrice. Semi-quantitative RT-PCR and Live-dead staining
was performed as mentioned above. The three vitamin C-
treated cultures (MS8, MS9, and MS12) were lysed and plasmid
stability was determined in by PCR using operon-specific
(parD2-F and parE2110-R, Supplementary Figure S3) and
kanamycin specific primers (aph-F and aph-R, Supplementary
Figure S3).
RESULTS
Organization and Transcriptional Profile
of parDE2 TA Operon of M. tuberculosis
The majority of 88 putative TA system in the M. tuberculosis
(Mtb) genome identified by comparative genomic analysis
have remained uncharacterized (Ramage et al., 2009). Since
the parDE2 TA system of Mtb was not annotated clearly,
it was necessary to establish the identity of the genes and
demonstrate that the ORFs are transcriptionally active and not
pseudogenes. Analysis of the Mtb H37Rv genome sequence
(Ramage et al., 2009) revealed the parDE2 operon (Rv2142A-
Rv2142c) as a canonical type II TA system with a 5′ antitoxin
gene followed by a toxin gene, sharing a 4 bp overlap (Figure 1A).
Blastp analysis of MParE2 and MParD2 amino acid sequences
revealed only 18 and 12% sequence identity with ParE and
ParD of RK2 plasmid, respectively (Figure 1B). The genetic
organization of the operon was determined by RT-PCR using
RNA prepared from different phases of growth with parDE2
specific primers. A single 530-bp product (confirmed by DNA
sequencing) corresponding to the predicted size indicated the
bi-cistronic nature of the parDE2 transcript (Figure 1C). No
product was amplified when the RNA was used without the
preceding reverse transcriptase step (data not shown). The above
results revealed (i) basal level transcriptional activity of the
parDE2 locus from exponential phase till late stationary phase
(Figure 1C) (ii) that parDE2 is not a pseudogene and (iii) the
parD2 and parE2 genes are transcribed as a single, bicistronic
transcript.
parDE2 Promoter Search
Since no promoter-like sequence was detected in silico in
the parDE2 locus by neural network prediction tools and
BPROM (SoftBerry), lacZ fusion constructs were produced
by fusing the 363 bp upstream region of the parD2 gene
(P363parD2), with the start codon of the lacZ reporter gene.
The fusion was ligated to the E. coli-Mycobacterium shuttle
vector, pMV261, at NotI/DraI sites and electroporated into
M. smegmatis mc2 155, producing strain MS2. The upstream
363 bp region demonstrated good promoter activity, which
increased progressively with time and was highest toward post-
stationary phase of the culture (Figure 2A). A control strain
(MS1) containing promoter-less lacZ exhibited no significant
β-galactosidase activity. These results showed that a functional
promoter was located in the 363 bp upstream region of parDE2
TA locus.
Mapping the 5′ End of the parDE2
Transcript and Identification of the
Promoter
To define the transcriptional start point (TSP) of the PparDE2
promoter, a 5′-RACE experiment was carried out. The major
∼300-350 bp band produced by RACE-PCR (Supplementary
Figure S1) was cloned and eight positive clones were selected
and sequenced. In each case the 5′ end of the cDNA revealed an
identical sequence, unambiguously indicating the transcriptional
starting point.
With reference to the TSP identified above, the promoter
region was defined based on the published information of
nucleotide distribution within the mycobacterial promoter
sequences (Newton-Foot and van Pittius, 2013). The results
are summarized in Figure 2B. Like most of the mycobacterial
promoters the parDE2 TSP (+1) is at a guanine (G), 103 bp
upstream from the GTG start codon of the parD2 gene and
preceded at −1 by a cytosine (C). A putative –10 region centerd
at 5′- TTCCAT -3′ and a corresponding -35 hexamer sequence 5′-
GTCACA -3′, separated by a 19 bp optimal stretch were observed
in the PparDE2 promoter (Figure 2B). The above sequences
matched well with other mycobacterial promoters recognized
by σ70 (Newton-Foot and van Pittius, 2013). Interestingly, the
identified parDE2 promoter was identical to a −35 consensus
sequence recognized by mycobacterial sigma factor J (σJ),
induced specifically during stationary phase (Hu and Coates,
2001), oxidative stress (Hu et al., 2004) and macrophage
invasion (Newton-Foot and van Pittius, 2013), suggesting its
possible role in regulation of the parDE2 locus under the
above environmental conditions. Indeed, we observed regulation
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FIGURE 1 | The parDE2 TA locus of Mycobacterium tuberculosis. (A) Genetic organization of the parDE2 operon with a 4 bp overlapping region. Gray arrows
indicate where the RT-PCR primers anneal. (B) ClustalW alignment of MParE2 and ParE of RK2 plasmid. Identical residues (∗); similar residues (:). Filled triangles
above MParE2 indicate the residues that were substituted by alanine. (C) Reverse transcriptase PCR using total RNA isolated from Mtb cells grown in broth culture
for 10, 20, and 30 days.
of the operon under oxidative stress, affecting the growth of
M. smegmatis cells (see results below, Figures 10A,B). However,
at this stage the regulation of parDE2 promoter by σJ under
oxidative stress is purely speculative and needs to be verified in
M. tuberculosis.
Autoregulation of the parDE2 TA Operon
in M. smegmatis
Based on the earlier reports of presence of an N-terminal
ribbon-helix-helix DNA-binding domain with auto-regulatory
activity in the ParD antitoxin of RK2 plasmid (Oberer et al.,
2002; Dalton and Crosson, 2010), and our own observations
demonstrating involvement of N-terminal residues of MParD2
in binding to the promoter DNA (Figure 3), we proceeded
to examine the involvement of MParD2 in transcriptional
regulation of the parDE2 operon in vivo. For this purpose,
plasmids (pMS3 and pMS4) were generated expressing P363-
lacZ fusion along with MParD2 or ParDE2 complex proteins
from a separate vector containing the groEL promoter (Methods;
Supplementary Figure S2) and β-galactosidase activity was
assessed in M. smegmatis mc2 155 cells. The cells harboring P363-
lacZ fusion alone (MS2) exhibited high promoter activity during
log phase growth (Figure 2C). Presence of the two proteins in
the form of ParDE2 complex repressed the promoter activity
∼two-fold (Figure 2C). The repression was increased to∼seven-
fold when MParD2 protein was present alone, suggesting that
stronger repression of the promoter could be due to higher
availability of free MParD2 protein in the cell (Figure 2C) (not
limited by complex formation with MParE2), for interaction
with the promoter DNA. In vitro interactions of MParD2 with
MParE2 also supported complex formation by the two proteins
(Figure 6). These results demonstrated that the parDE2 promoter
of Mtb is (i) transcriptionally active and (ii) negatively auto-
regulated by the MParD2 protein in the surrogate M. smegmatis
host.
Interaction of MParD2 with the parDE2
Promoter Region
A 200 bp DNA fragment upstream of parD2 start codon
(P200parD2) was end-labeled with [γ-32P]-ATP and T4
polynucleotide kinase, and used to test the DNA binding
abilities of MParD2 antitoxin and its variants by EMSA. A fixed
concentration of P200parD2 DNA was titrated with variable
amounts of MParD2 (0–36 µM, Figure 3A) and the optimum
concentration was determined. The antitoxin MParD2 could
efficiently bind to the labeled DNA fragment in a concentration-
dependent manner as observed by a clear shift in electrophoretic
mobility due to complex formation, with corresponding decrease
in free DNA (Figure 3A). It was observed that 18 µM of MParD2
was sufficient to bind with the entire 20,000 cpm radiolabelled
DNA probe leaving no detectable free probe and hence was used
in all the assays (Figure 3A).
MParD2 which belongs to the Unstab_antitox Superfamily
(cl09921) is predicted by PSIPRED (UCL) to contain four alpha
helices. DNA binding amino acid residues in the N-terminal of
MParD2 were predicted based on a Gaussian network model
(Haliloglu et al., 1997) using the DNABindProt prediction tool
(Haliloglu et al., 2005), and subsequently substituted by alanine.
Binding of L8A, V11A and E21A, MParD2 variants to the
promoter region was not affected due to mutation. However, the
S15A and R16A variants showed total loss of DNA binding ability
in gel-shift assays (Figure 3A).
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FIGURE 2 | MParDE2 Promoter identification and regulation. (A) M. smegmatis recombinants viz., MS1, harboring a promoter-less lacZ construct; MS2,
containing P363parD2-lacZ fusion construct and MS12, vector control strains were grown in 7H9 medium at 37◦C and β-galactosidase activity was measured
spectrophotometrically, after regular intervals. (B) The transcriptional start site (+1), putative −35 and −10 promoter elements along with parD2 and parE2
translational start sites are indicated in rectangular boxes determined by 5′-RACE PCR analysis. MParD2 amino acid residues substituted with alanine are
underlined. (C) Regulation of PparDE2 in M. smegmatis strains. β-galactosidase activity from different M. smegmatis strains harboring 363 bp parDE2 promoter
sequence fused with lacZ gene, co-expressing MParD2 or MParDE2 protein complex under the control of groEL promoter. Empty pMV261 vector, parD2 and
ParDE2 sequences without promoter were used as negative controls. Error bars indicate mean ± SD from three independent experiments.
DNA binding was also measured by a fluorescence
competition assay employing ANS as an extrinsic fluorescent
probe whose anilinonaphthalene groups fluoresce upon
interaction with the surface exposed hydrophobic residues
of the proteins. Addition of P200parD2 DNA to the MParD2
variants-ANS complexes quenched ANS fluorescence in all
except S15A and R16A variants (Figure 3B), which showed no or
negligible quenching of the probe and reflected no DNA binding,
supporting mobility shift results (Figure 3A). A conserved serine
residue at the 15th position in the ParD antitoxin of Rk2 plasmid
is also shown to be involved in forming the hydrophobic core of
the DNA binding motif (Oberer et al., 2002).
Growth Characteristics of E. coli and
M. smegmatis Strains Harboring parDE2
Genes
The proteins encoded by M. tuberculosis parDE2 operon were
overexpressed in E. coli for biochemical characterization. Protein
expression was induced by L-arabinose from araBAD promoter
in E. coli strains EC4 (parE2) and EC5 (parDE2). MParE2 protein
was detected 2 h after induction by immunoblotting. Expression
of ParE2 resulted in complete arrest of growth and replication of
the cells and a drastic reduction (∼5 log10) in CFUs vis-à-vis the
parDE2 containing strain (Figures 4A,B). On longer incubation
(>16 h post induction), the culture slowly recovered in growth
and the OD reached close to un-induced cells. When the inducer
was removed and replaced with fresh medium, the recovery was
faster, indicating the bacteriostatic nature of MParE2 on E. coli,
Figure 4C. It is not clear if the majority of the cells die and the
survivors recover or the cells are temporarily disabled and grow
back when the toxin is degraded. MParE2 protein concentration
in the recovered population was quite low after 20 h incubation
despite the presence of plasmid in the cells (data not shown)
possibly due to inducer exhaustion (Figure 4D).
EC4 cells were induced in different growth phases,
representing early-log (OD600 ∼0.33), late-log (OD600 ∼0.78),
early stationary (OD600 ∼1.1) and late stationary phase (OD600
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FIGURE 3 | Binding of MParD2 to promoter DNA by EMSA and ANS fluorescence assay. (A) A 200-bp parDE2 promoter DNA was obtained by PCR and
labeled with [γ-32P]-ATP. The labeled DNA was incubated with different concentrations of ParD2 (lanes 1–6) or with 18 µM heat-inactivated MParD2 (lane 7) or
ParD2 variant proteins. Specific and non-specific binding events are shown using unlabelled promoter DNA (lane 8) or BSA (lane 10). Lanes 9, 13, 14, 17, 20, and
25, showing super-shift EMSA using 18 µM His6-tagged protein and monoclonal anti-His Ab (18∗). Lane 11-25 shows electrophoretic mobility of the MParD2
variants. (B) Fluorescence emission spectra of 25 µM ANS bound to 5 µM of (I) MParD2, (II) ParD2-S15A, and (III) ParD2-R16A. The emission of ANS alone was
subtracted from the observed values of each variant. Measurements were taken at 25◦C with an excitation wavelength of 350 nm.
∼1.6). Growth of the cells was retarded in all the phases due
to MParE2 toxin expression. However, the toxicity was much
higher in the early growth phase resulting in ∼5 log10 reduction
in CFU in 4 h as compared to older cells from late stationary
phase, in which the extent of inhibition was diminished to ∼2
log10 only (Figure 4E). The magnitude of ParE2 expression was
lowest in the lag phase (OD600∼0.33), but growth inhibition was
maximum (Figure 4F). In the exponential phase (OD600∼0.78),
relatively more protein was produced but growth inhibition was
decreased. In the subsequent stages both protein expression and
inhibition were lower than the exponential phase (Figure 4F).
Since the amount of functionally active protein cannot be
accurately measured here, it can be inferred that the growth
phase dependent variation in MParE2 expression is not directly
linked to the observed growth inhibition.
In M. smegmatis no recombinant colonies were obtained when
pMS5 containing the toxin gene was electroporated in the tightly
controlled inducible pYUB1062 system, demonstrating enhanced
toxicity of MParE2 in mycobacteria. By contrast, MS6 and MS7,
containing the C-terminal deletion MParE2 variant and the
intact parDE2 locus respectively, grew normally like the vector
control (Figure 4G). Collectively, the data indicated that the
transcriptionally active parDE2 locus of M. tuberculosis harbors
a toxin - MParE2, which is neutralized by the cognate MParD2
antitoxin.
Effect of MParE2 Expression on Cellular
Viability and Morphology
To ascertain the cause of reduction in CFU counts of the MParE2
expressing cells (Figure 4B) during growth, the cultures were
examined for viability by live-dead assay. SYBR Green I, a
membrane-permeant nucleic acid stain, labels all cells in contrast
to propidium iodide (PI), a membrane-impermeant stain, which
enters cells with compromised membranes only. The percentage
of live cells calculated in the EC4 culture were 93± 5.3, 56.3± 4.2,
49 ± 2.3, 53.3 ± 1.6, 58.6 ± 3.1 and 84.6 ± 5.2% at 0, 2, 4, 8,
12, and 20 h post-induction respectively (Figure 5A). In contrast,
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FIGURE 4 | Growth Inhibition of Escherichia coli and M. smegmatis strains expressing MParE2. E. coli strains expressing parE2 (. . .); parDE2 (—); and
vector control constructs (—) were grown till OD600 ∼ 0.5, and induced with L-arabinose. (A) OD600 and (B) CFUs in the cultures. (C) MParE2 expressing EC4 cells
were induced with L-arabinose and grown for 20 h (. . .); or after 4 h of induction cells were washed and transferred in fresh LB media containing 0.2% D-glucose
(—); uninduced EC4 cells were used as control (—), and CFUs were monitored at regular intervals. (D) Immunoblotting of EC4 cells expressing MParE2. After
induction the cell lysates (150 µg protein/well) were resolved by SDS-PAGE and the protein was detected using monoclonal anti-His probe. (E) ParE2 expressing
EC4 cells from different growth phases were induced for 4 h and CFUs were determined. (F) MParE2 protein was estimated by western blotting as above.
(G) M. smegmatis strains containing pMS5(parE2), pMS6(parE2110), pMS7(parDE2) and pYUB1062 vector alone were streaked on 7H10 agar plates in the
presence of 0.2% acetamide and 50 µg ml−1 hygromycin. Each time point in the growth curve is an average of three experiments with standard deviations.
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FIGURE 5 | Effect of MParE2 expression on cell viability and morphology. (A) SYBR Green I/PI mediated cell viability assay. EC4 (ParE2) and EC5 (ParDE2)
cultures were harvested at regular intervals post induction, stained and percent viability corresponding to respective G/R ratios was determined from the standard
curve. The results represent average of three experiments with standard deviations. (B) The EC4 and EC5 cultures after 4 h induction were stained and visualized
under a fluorescent microscope, showing green live cells and red dead cells. (C) Scanning electron microscopic view of (I) EC4 and (II), EC5 cells, 4 h post induction;
blue arrows show wrinkled membranes and cellular blebbing.
the control EC5 strain remained >90% viable till the end of
the experiment (Figure 5A). Further, fluorescent microscopic
examination of 10 fields of each culture confirmed the above
results; roughly half of EC4 cells are seen to fluoresce green
indicating live cells (Figure 5B). As expected, the number of dead
cells in the MParE2 expressing culture was much higher than the
MParDE2 cultures after 4 h of protein expression. Sparfloxacin-
treated vector control cells displayed∼24.3± 3.7% viability after
4 h of exposure (data not shown). The combined results of the
CFU counts and cell viability assay demonstrated that, of the
∼6.3 × 108 CFUs present in the culture before induction of
ParE2, ∼50% cells die in 4 h after induction. Thus by deduction,
if the remaining 50% are alive, ∼3.15 × 108 colonies should be
produced. However, since only ∼7.7 × 103 CFUs were obtained
amounting to ∼0.002% of the live cells, it can be assumed that a
majority (99.9%) lose their ability to form colonies and enter into
a viable but non-culturable state.
We further validated the live-dead assay by parallel detection
of active gene expression by Reverse-transcriptase PCR (Adams
et al., 2003; Trevors, 2011; Li et al., 2014). This method is
based on the principle that if due to MParE2 expression, the
cells become ‘viable but non-culturable’, they would retain their
ability to carry out transcription, and the levels of specific
mRNAs would be comparable to the control; in case the cells are
dead, mRNA being unstable, the amount of transcripts would
be much lower. On quantitative estimation, it was observed
that the transcript levels of three reference genes (idnT, rpoD,
and rrsG) were not significantly different from those of the
vector control cells (Supplementary Figure S4), reiterating the
point that 99.9% of the MParE2 expressing live cells were non-
culturable.
To examine cellular integrity after MParE2 expression, nucleic
acid release in the medium was quantified in all the strains at
260 nm. No cytoplasmic content of the bacteria was found to
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FIGURE 6 | Interaction of MParD2 with MParE2 by GST Pull-down assay. The partially purified His6X-MParE2 protein mixture was incubated with
GST-MParD2 or GST tag alone, immobilized on glutathione-beads. MParE2 bound to the beads was detected by (A), SDS-PAGE followed by coomassie blue
staining. His6X-Domain 4 of Protective Antigen of Bacillus anthracis was used as non-specific protein-prey control. (B) Immunoblotted with Anti-GST Antibody.
(C) Anti-His Antibody. Pre-stained low range ladder (Bio-Rad) was used in all the experiments.
be released in the extracellular medium after induction (4 h) of
either strain (Supplementary Figure S5). Taken together, our data
revealed that MParE2 toxicity does not lead to immediate cell
lysis.
MParE2 expressing E. coli cells exhibited an elongated
phenotype as observed by SEM. The average length of the EC4
cells was 6.4 µm,∼3 times longer than the control EC5 cells with
an average cell length of∼2µm (Figures 5C). The latter exhibited
a smooth and intact cell surface, in contrast to toxin expressing
cells, that looked extensively corrugated, rough and displayed an
uneven surface with dimples.
In Vitro Interaction of MParD2 Antitoxin
with MParE2 Toxin
After neutralization of MParE2 toxicity by the MParD2 protein
during in vivo growth, in vitro interaction of the two proteins
was examined. SDS-PAGE analysis revealed the presence of both
His-MParE2 and GST-MParD2 proteins in the same fraction
eluted from the glutathione-sepharose affinity column. This
was confirmed by immuno-blotting using anti-GST and anti-
His monoclonal antibodies (Figure 6). In the absence of GST-
MParD2, His-MParE2 did not bind to the GST column and eluted
in the unbound fraction. Also His-tagged PA-D4 did not bind
to GST-MParD2 on column and most of it came out in the
unbound fraction, demonstrating specificity of MParD2-MParE2
interaction (Figure 6).
Inhibition of Mtb DNA Gyrase
Supercoiling Activity by MParE2 Toxin
Reconstitution of the DNA gyrase holoenzyme (A2B2) from
equal amounts of GyrA and GyrB subunits and further
purification with gel filtration chromatography provided the
active enzyme corresponding to an apparent mass of 345 kDa,
confirmed by blue-native PAGE analysis (data not shown). The
specific activity of the purified, recombinant Mtb DNA gyrase
holoenzyme was approximately 2.3 × 103 U mg−1; much lower
than that of E. coli and Bacillus subtilis (>10,000 U mg−1; Orr and
Staudenbauer, 1982; Reece and Maxwell, 1989). No supercoiling
was observed when ATP was omitted from the reaction mixture
(data not shown).
The DNA gyrase poisons such as ParE, CcdB and quinolone
antibiotics stabilize/trap the reaction intermediates by binding
to the cleaved DNA-gyrase complex and stall replication fork
movement (Bernard and Couturier, 1992; Jiang et al., 2002).
In the agarose gel, accumulation of linear dsDNA species after
addition of SDS and proteinase K indicates inhibition of gyrase
activity. Based on this mechanism, we examined the mode of
action of the mycobacterial MParE2 on DNA gyrase. The DNA
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FIGURE 7 | Modulation of DNA gyrase activity of Mtb by MParE2 and MParD2 proteins. pBR322 plasmid DNA (1 µg) was used as a substrate in the DNA
gyrase supercoiling assay. (A) DNA gyrase supercoiling assay. Relaxed (RLX), negative control; supercoiled (SC), positive control; L, linearized and OC, open circular
form of pBR322. (B) inhibition of DNA gyrase activity by MParE2. All the samples contained 1 unit of DNA gyrase holoenzyme. M, 1 kb DNA ladder; 1, heat
denatured 2.6 µM MParE2. For control experiments 0, 2 and 5 µg ml−1 sparfloxacin was used. (C) Inactivation of MParE2 toxicity by MParD2. 5.3 µM MParE2
pre-mixed with 0, 3.6, 7.2, and 10.9 µM MParD2 prior to mixing with DNA Gyrase. 1, heat denatured 10.9 µM MParD2. (D) Left lane, 5.3 µM MParE2 and 10.9 µM
MParD2 pre-incubated for 30 min and added to 1 unit of DNA gyrase reaction mix; right lane, 5.3 µM MParE2 pre-incubated with 1 unit of DNA gyrase for 30 min
and 10.9 µM MParD2 added to assay mix.
supercoiling assay using a relaxed pBR322 plasmid as substrate
is shown in Figure 7A. MParE2 inhibited DNA gyrase activity,
resulting in accumulation of the cleaved DNA intermediate, while
the amount of supercoiled DNA decreased progressively with
increasing toxin concentration (Figure 7B). When MParE2 was
heat inactivated, the supercoiling reaction progressed normally,
converting most of the relaxed pBR322 DNA into the supercoiled
form while the concentration of intermediate cleavage product
reduced drastically (Figure 7B), indicating that the inhibition was
indeed due to MParE2 protein. In control experiments, addition
of 2 and 5 µg ml−1 sparfloxacin to the assay mixture, also
resulted in accumulation of cleavage intermediates and gradual
decrease in the amounts of supercoiled DNA as seen with MParE2
(Figure 7B).
Reversal of DNA Gyrase Inhibition by
MParD2
The inhibitory effect of MParE2 on Mtb DNA gyrase mediated
supercoiling was blocked by pre-incubation of the toxin with
MParD2 protein for 30 min (Figure 7C). Approximately 10.9µM
MParD2 antitoxin (∼2 times) was sufficient to abrogate the
inhibitory effect of 5.3 µM MParE2 toxin in the in vitro assay.
The same amount of heat inactivated MParD2 was unable to
neutralize the inhibition caused by MParE2 (Figure 7C); only
a few intermediates of the trapped cleavable complexes were
observed. Interaction of MParD2 with MParE2 for 30 min before
adding to the rest of the reaction mixture allowed the gyrase
reaction to proceed normally (Figure 7D). However, MParD2
could not reverse the inhibition when DNA gyrase was pre-
incubated with MParE2, indicating that the antidote is unable to
rescue an ‘MParE2-poisoned’ DNA-gyrase complex (Figure 7D)
unlike other known antitoxins (Pedersen et al., 2003). The in vitro
activity of MParD2 is consistent with its in vivo role in preventing
ParE2 mediated killing.
Interaction of MParE2 with Mtb Gyrase A
and B Subunits
The interaction between MParE2 and the individual gyrase
subunits were examined by ITC and SPR. In ITC, the thermal
profile of Mtb GyrB and MParE2 displayed positive peaks
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FIGURE 8 | Interaction of MParE2 with GyrB by SPR and ITC studies. ITC measurements were performed at 25◦C using the MicroCal iTC200 system (GE
Healthcare). Binding isotherms were integrated and analyzed using Origin v7.0 software (MicroCal). (A) 70 µM of GyrA and (B) 70 µM of GyrB were titrated against
700 µM ParE2. SPR analysis using BIAcore T200. His6-GyrB subunit was captured by Anti-His MAb immobilized on a CM4 sensor chip at a surface density of
2,500 RU. The analytes were injected over the immobilized ligands and analysis was carried out with different dilutions at a flow rate of 20 µl min−1 followed by a
dissociation time of 600 s. (C) Sensogram (Resonance/Responsive units vs. Time) shows the binding kinetics of MParE2 with GyrB at different dilutions. (D) Best fit
curve of change in RUs with varying MParE2 concentrations.
indicating an endothermic binding interaction (Figure 8B).
However, the binding was weak, as indicated by lack of saturation.
No interaction of MParE2 was detected with the Mtb GyrA
subunit (Figure 8A). Consistent with ITC data, the association
of MParE2 toxin with GyrB subunit, when monitored by SPR,
indicated that the interaction was moderate in strength with
a Kd M of 4.75E-6 (Figures 8C,D). No binding was observed
with GyrA under these conditions. In a control experiment,
interaction of sparfloxacin with GyrA showed Kd M = 9.228E-
8 (data not shown) indicating that the GyrA bound to the chip
was properly folded and immobilized. From these results it is
concluded that MParE2 interacts with GyrB subunit albeit with
relatively lower affinity under in vitro conditions. The ATPase
activity of GyrB in the presence of varying concentrations of
MParE2 toxin was measured using radiolabelled γ-32P-ATP as
substrate. No effect on the ATPase activity was observed after
1 h of incubation over a range of 0.66 to 16 µM of MParE2,
demonstrating that it does not interfere with the ATP binding site
of GyrB (Supplementary Figure S6).
Identification of C-terminal Amino Acid
Residues Critical for Toxicity of MParE2
in E. coli
The residues essential for biological activity of MParE2 were
identified by deletion and site-directed mutagenesis. In silico
structural analysis of MParE2 revealed that a 23-residue stretch
at the C-terminal of the protein is free, forming no secondary
structure. Hence, we assumed that mutations in this region are
not likely to destabilize the protein. To this end, we created
MParE2 deletion variant, by deleting 10 amino acid residues
from the C-terminal end. It was found that deletion of only 10
residues from the C-terminus rendered it non-toxic both in E. coli
and M. smegmatis (Figure 4F). The E. coli cells expressing wild
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type MparE2 revealed ∼5 log10 decrease after 2 h of induction
compared to MParE2110 strain (EC6), which grew normally,
showing∼1 log10 increase in the CFU (Figures 9A,B).
Following the lead from C-terminal deletion, we proceeded
to identify the individual residues responsible for toxic activity;
six amino acid residues namely: P92, E96, E98 I99, S100, and
R102, located in the C-terminus were altered to alanine by
SDM and their effect on cellular growth was monitored. The
E98A and R102A variants showed total loss in toxicity as the
cells grew normally after induction (Figure 9A). The effect
of alanine substitutions at positions P92A, E96A, I99A, and
S100A reduced MParE2 toxicity to varying degrees but was
not as dramatic as E98A and R102A (Figure 9B). Protein
expression in each case was confirmed by immuno-blotting after
4 h induction (Figure 9C). Thus identification of the specific
C-terminal residues critical for toxicity of the protein is an
important step in understanding MParE2 mediated intoxication
of cells.
Stress Response of M. smegmatis
Containing the parDE2 Operon
Based on the previously described results demonstrating activity
and autoregulation of the MparDE2 promoter in M. smegmatis
(Figure 6), we designed the following experiment on the premise
that if, in response to specific environmental stresses, the
MparDE2 operon and certain proteases are activated, the cells will
produce free MParE2 protein owing to the differential stability of
MParD2. The toxic effect would be visible on cellular viability and
quantifiable by CFU counts. Hence M. smegmatisMS8 containing
the wt-parDE2 operon, MS9 containing C-terminal truncated
parDE2 operon and MS12 vector control strains were generated
and subjected to a variety of stress conditions encountered within
the host.
Diethylenetriamine/nitric oxide-adduct, used as a reagent to
produce oxidative stress in cell culture experiments, caused
uniform reduction in the CFUs with time in all the three
M. smegmatis strains. Hence to minimize its effect the oxidative
stress was evaluated in younger cells (OD600 ∼0.6) with short
exposure time. Early log phase cultures of MS8, after 1–2 h
of DETA/NO exposure, exhibited ∼0.7–1 log10 decrease in
viability compared to MS9 strain and MS12 strains. The effect of
DETA/NO was highly pronounced in the late log and stationary
phases with ∼1.5 log10 decrease in CFUs as compared to the
two control strains (Figure 10A). However, this decrease could
also be due to reduction in fitness of the population with time,
exacerbating the effect of MParE2.
The three strains were also exposed to vitamin C (VC), which
is known to produce oxidative stress. Unlike DETA/NO, no
toxicity was observed on the growth rate or cell viability in
the control strains with 6 mM VC during the course of 8 h,
while MS8 cells showed ∼1.4–1.5 log10 reduction in viability
(CFU) in all the growth stages (Figure 10B). The observed
reduction in CFU under oxidative stress could be due to two
reasons; either the cells are dead or they have become viable but
non-colony forming like E. coli. Molecular analysis of the VC-
treated MS8 strain by semi-quantitative RT-PCR and western
blotting indicated transcription of both the parD2 and parE2
genes (Figure 10C), and presence of MParE2 protein in the
cells (Figure 10C). Visual examination of the Live-dead stained
cultures, a widely accepted method to measure cellular viability
(Frampton et al., 2012), showed only marginal increase in the
number of dead cells in VC treated MS8 than in the MS12 culture
(Figure 10D), which did not match with the CFU counts. Lastly,
presence of the plasmid in all the three strains was confirmed by
PCR amplification and the possibility of plasmid instability was
ruled out (Supplementary Figure S7A). Thus, MParE2 seems to
generate VBNCs in M. smegmatis, as observed in E. coli before.
Colony forming units enumeration of MS8 cells subjected to
hypoxia revealed differential regulation in comparison to MS9
and MS12 strains. A general decrease in CFUs of all the strains
with time was observed during the experiments presumably due
to natural cell death. After exposure to hypoxia a decrease in
CFU of ∼0.5–0.6 log10 occurred in wt-parDE2 harboring MS8
cells at 5 and 10 days, respectively (Supplementary Figure S7B),
suggesting that the parDE2 operon was regulated under hypoxia.
No significant change in cell density or CFUs of the M. smegmatis
strains was observed under nutrient starvation and heat stress,
suggesting that the parDE2 operon did not respond to these
stress conditions (Supplementary Figures S7E,F). Similarly, the
operon remained unaffected under iron depletion or acid stress
(Supplementary Figures S7C,D).
DISCUSSION
To cope with environmental stresses within the host,
M. tuberculosis enters a transient state of dormancy characterized
by a decrease in growth rate and metabolic activity. Since
these cells do not multiply, they escape detection by culture-
based diagnostic methods. This small, antibiotic-tolerant
population, called the persister is an impediment in eradication
of tuberculosis. In this light, MParE2 protein, an inhibitor
of DNA gyrase, a key enzyme involved in the process
of DNA replication appeared to be an ideal candidate to
explore.
The proteins encoded by Mtb parDE2 operon were
overexpressed in E. coli for biochemical characterization and
their biological activity was examined in the saprophytic strain
M. smegmatis, as it is physiologically closer to M. tuberculosis
H37Rv but lacks homologs of most of the predicted TA loci
of Mtb (Ramage et al., 2009). This provided an ideal system
to investigate the parDE2 genes in-isolation, as redundancy,
cross-talk and functional overlap commonly observed between
TA systems hamper their biochemical characterization (Zhu
et al., 2010; Sala et al., 2014). Overall, the growth inhibition
of both M. smegmatis and E. coli by MParE2, and its reversal
by the cognate MParD2, indicated that MParE2 toxicity is
not restricted to the mycobacterial genus only, given the
conservation of DNA gyrase among bacteria. Co-transcription
of the parDE2 operon as a single primary transcript, and
neutralization of MParE2 toxicity by MParD2 both in vivo and
in vitro, validated MParDE2 as an archetypal TA system of
Mtb.
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FIGURE 9 | Effect of C-terminal mutations on toxicity of parE2. E. coli strains expressing MParE2 C-terminal deletion (10 residues) and six point mutants,
P92A, E96A, E98A, I99A, S100A, and R102A, were grown in LB broth and induced with L-arabinose and growth was measured. (A) Optical density; (B) viable
counts of the cultures represent average of three independent experiments with standard deviations. (C) Immunoblotting of MParE2 variants. Equal amount of total
protein extract (150 µg/well) of the strains were subjected to immunoblotting using Anti-His monoclonal antibody. Wild type His6X-MParE2 was used as a positive
control.
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FIGURE 10 | Modulation of MparDE2 locus in M. smegmatis under stress conditions. Cultures from different ages were subjected to different stress
conditions. CFU counts were determined before and after stress treatment. (A) Cultures from different growth phases, OD600 ∼0.6 (mid log), 1.4 (early stationary)
and 2.1 (late stationary) were exposed to oxidative stress with 10 mM DETA/NO, and CFUs were determined after 1 and 2 h. (B) Cells in different growth phases
were exposed to 6 mM Vitamin C. Samples were removed after 2 and 8 h, washed and plated for CFU counts. The data presented are mean ± SD of triplicate
samples and are representative of three individual experiments. (C), (i) Semi-quantitative RT-PCR analysis of parD2, parE2, and parDE2 transcripts using total RNA
from MS8 cells; (ii) immunoblotting of Vitamin C-treated (8 h) MS8 cell lysate, using ParE2 specific polyclonal antisera raised in Balb/c mice. M, pre-stained protein
ladder (PageRuler). (D) Live-dead staining of M. smegmatis recombinants after 8 h of Vitamin C treatment.
MParE2 differs from other toxins like Rk2-ParE (Jiang et al.,
2002) and CcdB (Bernard and Couturier, 1992) in binding to
the GyrB and not the GyrA subunit. The DNA gyrase poisons
either bind to and stabilize the gyrase-DNA cleavage complex,
a hallmark of stalled DNA gyrase activity or inhibit the ATPase
activity encoded in the GyrB subunit (Collin et al., 2011). Since
the ATPase activity encoded in the N-terminus of GyrB, was not
affected in our studies, we surmise that the binding residues are
far from the active site, implying involvement of the C-terminal
domain in MParE2 binding. The binding sites on the target DNA
gyrase holoenzyme vary for different inhibitors, as shown by
susceptibility of a CcdB resistant E. coli to ParE toxin (Roberts
et al., 1994). The amino acid residues involved in binding
of CcdB, quinolones and some ParE proteins all map in the
GyrA subunit (Madurga et al., 2008), mostly within the QRDR
(quinolone resistance-determining region), while coumarins and
cyclothialidines are known to bind to the GyrB subunit (Madurga
et al., 2008; Collin et al., 2011). Thus, though MParE2 inhibits
gyrase activity by stabilizing the cleavage complex like other TA
toxins, its binding preference is for GyrB and not GyrA like the
others. From the available data it is not possible to predict how
MParE2 might be inhibiting the enzyme activity. It could bind
to GyrB subunit and cause a conformational change affecting
catalytic activity of the holoenzyme. Alternatively, binding of
MParE2 may stabilize the gyrase-DNA complex in a cleaved state
by bringing the residues of the quinolone binding pocket closer
within the QRDR, as shown by Heddle and Maxwell (2002).
Solving the structure of the Mtb DNA-gyrase-MParE2 complex
will shed more light on the mechanism of inhibition of gyrase by
MParE2.
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The rapid fall in CFUs (∼105 fold) of E. coli upon MParE2
expression, initially thought to be cell death due to toxicity, did
not match with live cell counts (more than 50%) obtained by live-
dead staining assay. Quantitative estimation of transcriptional
activity of specific genes, live-dead staining and CFU counts
together demonstrated that majority of the live cells were viable
but non-culturable (VBNC), a survival strategy adopted by many
bacterial species (Li et al., 2014; Ayrapetyan et al., 2015). Thus
upon MParE2 expression, E. coli responded in three different
ways, (i) half the population died, presumably an altruistic
response for self-preservation of the population till the return of
favorable conditions (Lennon and Jones, 2011; Pinto et al., 2011),
(ii) the live cell population stochastically differentiated into two
phenotypically distinct subpopulations wherein a major portion
lost their ability to form colonies and entered a quiescent state
(Ayrapetyan et al., 2015), and (iii) a minor (∼0.002%) population
of the live cells retained their ability to form colonies, showed
slow growth rate as the only sign of intoxication and are believed
to be progenitors of persister cells (Figure 4B). The reason for
the observed phenotypic diversity of the population has been
attributed to variation in the level of toxin expression in the cells,
suggestive of a bistability/tristability-like phenomenon (Dubnau
and Losick, 2006; Feng et al., 2014a). A similar phenomenon
was reported earlier (Shah et al., 2006) in a recombinant E. coli
culture expressing green fluorescent protein under a ribosomal
promoter, active in dividing cells only. A small number of
cells that stochastically entered into dormancy appeared dim
due to diminished cellular activity. Thus, we hypothesize that
though MParE2 expression caused growth inhibition of the
entire population (Figures 4AB), the magnitude of toxin protein
expression may be variable in individual cells, determining their
fate. We assume that majority of the viable cells that crossed
a threshold showed the VBNC phenotype, while those below
the threshold were less affected and do not show the extreme
effects of toxin. This is similar to the toxin threshold-dependent
generation of VBNC and persisters, reported earlier in case of
HipBA TA module (Rotem et al., 2010).
In the light of involvement of TA systems in stress
alleviation/tolerance (Lewis, 2007; Wu et al., 2012), activation
of the parDE2 operon and release of free toxin specifically
under oxidative stress, a condition known to prevail in the host
macrophages, strongly argues for its relevance in host niches. As
observed in E. coli, expression of MParE2 in M. smegmatis also
stochastically generated a minor colony forming and a major
non-culturable quiescent population, suggesting operation of
a common bet-hedging strategy mediated by the toxin in the
two evolutionarily distant bacterial species. Our results together
suggest that ParDE2 TA system of Mtb could be a key component
of the mycobacterial stress tolerance arsenal to evade the host
generated immune onslaught.
CONCLUSION
Considering the involvement of TA modules in regulating critical
cellular functions like growth and development, programmed
cell death and virulence determinants, e.g., biofilm formation
and persistence of pathogenic bacteria (Wen et al., 2014),
investigation of the parDE2 operon of Mtb looks promising for
developing strategies to control the disease. Differentiation of
MParE2 expressing culture into phenotypically distinct VBNC
populations, points to an ingenious program for long-term
survival and producing a chronic infection. The inherent
behavioral heterogeneity revealed by MParE2 expressing cells
suggests an effective mechanism of adaptation to environmental
stresses potentially leading to persistence and merits further
investigation. Work is in progress to study the role of parDE2
genes in the pathogenicity of Mtb.
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